Westlake Chemical Q3 revenue misses estimates

Westlake Chemical Partners LP

30/10/2025 10:48

Overview

Westlake Chemical Q3 revenue missed analyst expectations

Net income for Q3 2025 decreased compared to Q3 2024

Company renewed Ethylene Sales Agreement through 2027 at existing terms

Outlook

Company renewed Ethylene Sales Agreement through 2027 at existing terms

Result Drivers

ETHYLENE SALES AGREEMENT - Stable cash flows maintained despite declining spot ethylene prices due to Ethylene Sales Agreement

HIGHER MAINTENANCE EXPENSES - Decrease in MLP distributable cash flow due to higher maintenance capital expenditures

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Miss
$276.54 mln
$303 mln (1 Analyst)
Q3 EPS
$0.42
Q3 Net Income
$86.21 mln
Q3 EBITDA
$126.07 mln
Q3 Gross Profit
$99.42 mln
Q3 Income from Operations
$91.97 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the commodity chemicals peer group is "buy"

Wall Street's median 12-month price target for Westlake Chemical Partners LP is $25.50, about 25.7% above its October 29 closing price of $18.95

The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 12 three months ago

Press Release: ID:nBw1cjWqWa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)